<?xml version='1.0' encoding='utf-8'?>
<section xmlns:ns0="http://www.w3.org/2001/XInclude">
  <num>48-841.02</num>
  <heading>Definitions.</heading>
  <text>For the purposes of this chapter, the term:</text>
  <para>
    <num>(1)</num>
    <text>“FDA” means the federal Food and Drug Administration.</text>
  </para>
  <para>
    <num>(2)</num>
    <text>“Off-label use” means the use of a prescription drug for human use to treat a condition that is not included in the labeling for that medication, as approved by the federal Food and Drug Administration.</text>
  </para>
  <para>
    <num>(3)</num>
    <text>“Prescriber” means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs for human use in the course of a professional practice.</text>
  </para>
  <annotations>
    <annotation doc="D.C. Law 17-131" type="History">Mar. 26, 2008, D.C. Law 17-131, § 202, 55 DCR 1659</annotation>
    <annotation doc="D.C. Law 17-353" type="History">Mar. 25, 2009, D.C. Law 17-353, § 309(b), 56 DCR 1117</annotation>
    <annotation type="Effect of Amendments"><cite doc="D.C. Law 17-353">D.C. Law 17-353</cite>, in par. (2), substituted “prescription drug for human use” for “prescription drug”; in par. (3), substituted “prescription drugs for human use” for “prescription drugs”.</annotation>
  </annotations>
</section>
